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Abstract
Intrahepatic and extrahepatic metastases are common findings in hepatocellular carcinoma (HCC). Insulin-like
growth factor 2 (IGF2) expression is frequently induced in HCC, and serum IGF2 levels correlate with the presence
of extrahepatic metastases. Yet, the role of IGF-induced signaling in the dissemination of HCC remains unclear.
We have previously observed elevated IGF2 levels in tumors with metastatic potential in an HCC mouse model.
Here, we demonstrate that inhibition of IGF2, or its receptor IGF1R, impairs the migration and invasion activities of
murine HCC cells. Furthermore, inhibition of IGF1R also impairs the ability of HCC cells to colonize the lungs after
introduction into the circulation through the tail vein but does not impair subcutaneous tumor growth. Collectively,
these findings suggest that IGF1R-mediated signaling plays a causative role in tumor dissemination but is not
required for tumor growth per se. Although previous studies indicate that IGF ligands can signal through IGF1R/
insulin receptor (IR) heterodimers, and IR-A homodimers, we demonstrate that the IR is not required for invasion
and metastasis by HCC cells. Finally, we identify matrix metalloproteinase 2 as a mediator of the invasive pheno-
type downstream of IGF1R-induced signaling. Thus, our studies demonstrate the importance of IGF2-induced sig-
naling in the dissemination of HCC cells.
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Introduction
More than 600,000 new cases of hepatocellular carcinoma (HCC)
are diagnosed each year, with a survival rate of less than 5% and an
average survival of less than 1 year after diagnosis [1]. Various growth
factors and their respective receptors have been identified as modula-
tors of cell proliferation and differentiation in HCC. Among these, the
insulin-like growth factor (IGF) axis has been implicated as an impor-
tant mediator of proliferation and response to chemotherapy [2,3].
The IGF system consists of two small, secreted ligands, IGF1 and
IGF2; three cell membrane receptors, IGF1 receptor (IGF1R), insulin
receptor (IR) and IGF2 receptor (IGF2R); and six high-affinity IGF
binding proteins, IGFBP 1 through 6. IGF1R with a 70% homology
to IR is a heterotetrameric (α2β2), disulfide-bonded, transmembrane
glycoprotein containing extracellular ligand binding and intracellular
tyrosine kinase domains [4]. The IGF1Rβ subunit binds cytoplasmic
adapter proteins, thereby propagating the signaling cascade.
Binding of IGF1 or IGF2 to IGF1R results in receptor oligomeriza-
tion, activation of protein tyrosine kinase activity, intermolecular recep-
tor autophosphorylation, and phosphorylation of cellular substrates,
such as the IR substrate (IRS) proteins and the Shc adapter protein
that, consequently, lead to gene activation, DNA synthesis, and cell pro-
liferation [5]. In addition, IGF-mediated signaling may occur through
IGF1R and IR homodimers or through IGF1R/IR hemireceptor
complexes [6]. In contrast, IGF2R, which is structurally unrelated to
IGF1R, does not exhibit cytoplasmic kinase activity, but it regulates
IGF2 turnover and bioavailability through receptor-mediated endo-
cytosis and subsequent degradation [7].
Address all correspondence to: Brian C. Lewis, University ofMassachusetts Medical School,
364 Plantation St, LRB 521, Worcester, MA 01605. E-mail: Brian.Lewis@umassmed.edu
1B.C.L. is the recipient of a Career Development Award in the Biomedical Sciences from
the Burroughs Wellcome Fund and is a Liver Scholar of the American Liver Foundation.
This study was supported by National Institutes of Health grant CA121171 (B.C.L.).
2This article refers to supplementary material, which is designated by Figure W1 and is
available online at www.neoplasia.com.
Received 13 March 2009; Revised 29 May 2009; Accepted 1 June 2009
Copyright © 2009 Neoplasia Press, Inc. All rights reserved 1522-8002/09/$25.00
DOI 10.1593/neo.09476
www.neoplasia.com
Volume 11 Number 9 September 2009 pp. 835–845 835
Alterations in the IGF signaling pathway have been described in
several human tumors including Wilms tumors, colon, lung, breast,
and prostate carcinomas, as well as HCC [8–13]. The expression of
IGF2, which is high in the fetal liver and the early neonatal period
but strongly reduced in adult humans, mice, and rats, is strongly
reactivated in HCC and in animal models of the disease and may
contribute to hepatocarcinogenesis through an autocrine mechanism
[14–21]. Besides the direct transcriptional induction of IGF2, addi-
tional mechanisms, such as reduction of IGFBP levels and inactivation
of IGF2R by mutation and loss of heterozygosity, may contribute to
elevated IGF2 bioavailability in HCC cells [22–27]. Transgenic expres-
sion of IGF2 leads to HCC, further supporting a causative role for
IGF2 in this malignancy [28].
Yet, the mechanisms through which IGF2-induced signaling contrib-
utes to liver tumorigenesis remain unclear. We previously demonstrated
the existence of elevated IGF2 messenger RNA (mRNA) levels in
murine HCCs with enhanced metastatic potential relative to those
with low metastatic potential [21], consistent with findings correlating
serum IGF2 levels and extrahepatic metastases [29]. We therefore
sought to determine the role played by IGF2-induced signaling in vari-
ous tumor-associated phenotypes including metastasis. Here, we show
that IGF2-induced signaling through the IGF1R, but not the IR, is
required for the ability of HCC cells to migrate, invade, and colonize
the lungs. Importantly, the migration and invasion phenotypes seem
to require signaling through the downstream adapter IRS2, but not
IRS1, and the induction of matrix metalloproteinase 2 (MMP2). These
findings confirm the importance of IGF signaling in hepatocarcino-
genesis and suggest the significance of different signaling pathways
downstream of IGF1R activation.
Materials and Methods
Cell Lines
The MM189 and BL322 HCC cell lines have been previously de-
scribed [30,31]. RNAi-mediated depletion of IGF2, IRS1, IRS2,
IGF1R, and IR was achieved by infecting the MM189 murine HCC
cell line with pLKO-based lentiviruses encoding short hairpin RNA
(shRNA) targeting the appropriate mRNA (Open Biosystems,Huntsville,
AL). Infected cells were selected in 8 μg/ml puromycin (EMD Bio-
sciences, Gibbstown, NJ). Resistant cells were then analyzed by immuno-
blot analysis to determine gene knockdown efficacy.
Immunoblot Analysis
Immunoblot analysis was conducted as previously described [30].
Conditioned medium was collected from confluent cells grown in
serum-free medium for 48 hours and concentrated using centrifugal
filter devices according to the manufacturer’s protocol (Millipore,
Billerica,MA).The following primary antibodieswere used: anti-IGF1Rβ
(1:1000; Santa Cruz Biotechnology, Santa Cruz, CA), anti-IR (1:1000;
Santa Cruz), anti-IRS1 (1:1000; Millipore), anti-IRS2 (1:1000;
Millipore), IGF2 (1:1000; R&D Systems, Minneapolis, MN), IGF1
(1:1000; R&D Systems), and antiβ-actin (1:5000; Santa Cruz).
Cell Proliferation Assay
Cell proliferation assays were performed as previously described
[30]. The proliferation curves were constructed by calculating the
mean value of optical density measurement at 490 nm using a 96-well
plate reader and repeated at least three times.
Migration and Invasion Assays
Migration and invasion assays were performed as described in our
previous studies [30]. The percent invasion was calculated as the num-
ber of invading cells divided by the number of migrating cells. The per-
cent invasion was then normalized to get the invasion index, with the
value for the control cell population set to 1. All experiments were
performed in duplicate and repeated a minimum of three times. Data
shown are from representative experiments. For IGF2 rescue, serum-
free conditioned medium from confluent cells was filtered using a filter
with a 30-kDa size exclusion pore according to the manufacturer’s pro-
tocol (Millipore). This conditioned medium was used in the transwell
insert instead of serum-free medium. For IGF1R inhibition, cells were
cultured for 12 hours in the presence of AG1024 (EMD Biosciences)
before placement in the chambers.
Lung Colonization Assay
Six-week-old male nude mice were placed in a tail vein injector and
restrainer, the heated tail was cleaned with an alcohol swab, and 105 cells
in 300 μl of sterile PBS were injected into the tail vein. Pressure was
applied to the injection site for several seconds to prevent bleeding.
After 25 to 28 days, mice were killed, and their lungs were harvested
for paraffin embedding, sectioning, and histologic examination after
hematoxylin and eosin staining. The total number of lesions per
lung was determined by counting under a light microscope, and the
total tumor area was calculated using IPLab software (BD Biosciences,
Rockville, MD). Six animals were included in each group, and each
experiment was performed at least twice. Data are shown for represen-
tative experiments. All experiments were approved by the University of
Massachusetts Medical School Institutional Animal Care and Use
Committee and performed in accordance with guidelines approved
by the US Public Health Service.
Subcutaneous Tumor Formation
A total of 106 of either knockdown or control cells were suspended
in 100 μl of sterile PBS and injected subcutaneously (SC) into left or
right flank of the same 6-week-old male nude mice. After 10 to 12 days,
mice with SC injection were killed, and the tumors were weighed and
processed. Four to six animals were included in each group, and each
experiment was performed at least twice. Data are shown for represen-
tative experiments.
Quantitative Reverse Transcription–Polymerase
Chain Reaction
Total RNA was isolated from cell lines as previously described [21].
Two micrograms of RNA was reverse-transcribed into complementary
DNA (cDNA) using Superscript first-stand cDNA synthesis system
according to the manufacturer’s manual. The cDNA were amplified
in a 7300 Real-Time PCR System (Applied Biosystems, Foster City,
CA) using SYBR Green Master PCR mix for Snail, Twist, and MMP3
amplification, or TaqMan Universal Master mix for MMP2, MMP9,
and β-actin amplification (Applied Biosystems). All amplifications were
performed in quadruplicate. For experiments involving inhibition of sig-
naling pathways, cells were cultured for 36 hours in the presence of
AG1024 (EMD Biosciences), PD98059 (Sigma, St. Louis, MO), or
LY294002 (Invitrogen, Carlsbad, CA), which are specific inhibitors of
IGF1R, MAP kinase kinase, and phosphoinositide 3 (PI3) kinase, re-
spectively, before the isolation of total RNA.
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All values were normalized to an endogenous β-actin control. The
relative quantification value of each target gene in IGF1R knockdown
cells relative to vector control cells is expressed as 2−(C t − C c), where C t
and C c are the mean normalized threshold cycle difference for the
knockdown and control cells, respectively. The primer sequences used
to amplify individual genes are listed below.
Snail-F: CTGCAACCGTGCTTTTGC
Snail-R: CACATCCGAGTGGGTTTGG
Twist-F: CACGCAGTCGCTGAACGA
Twist-R: GACCTGGTACAGGAAGTCGATGT
MMP3-F: AGGAGCTAGCAGGTTATCCTAAAAGC
MMP3-R: TAGAAATGGCAGCATCGATCTTC
MMP9 (Mm006001164_g1; Applied Biosystems)
MMP2 (Mm00439506_m1; Applied Biosystems)
β-actin (Mm00607939_s1; Applied Biosystems)
Zymography
The identification of MMP2 proteolytic activity was performed
using gelatin zymography by electrophoresis of serum-free conditioned
medium collected from confluent cells. Serum-free conditioned me-
dium was concentrated using centrifugal filter devices according to
the manufacturer’s protocol (Millipore). After quantification of pro-
tein concentration by Bio-Rad protein assay (Bio-Rad Laboratories,
Hercules, CA), a total of 30 μg of concentrated conditioned medium
was loaded into 10% SDS-PAGE supplemented with 0.1% gelatin.
After electrophoresis, gels were incubated in renaturing buffer (10 mM
Tris pH 7.4, 2.5% Triton X-100; Sigma) for 30 minutes at room tem-
perature, then incubated in developing buffer (Invitrogen) for 30 min-
utes at room temperature, followed by incubation in fresh developing
buffer at 37°C for overnight. Gels were stained with Coomassie Brilliant
Blue R-250 (Sigma) and washed in a solution containing 10% acetic
acid and 30% methanol (Fisher Scientific, Pittsburgh, PA).
Results
IGF2 Induces Migration and Invasion Phenotypes
Through IGF1R
Our previously published data indicated that IGF2 mRNA levels
correlated with metastatic potential in a mouse model for HCC
[21,31], and published work has correlated serum IGF2 levels with
extrahepatic metastasis in HCC patients [29]. We have additionally
described murine HCC cell lines, derived from tumors induced in
our model, with different capabilities in cell culture migration and in-
vasion assays and have shown that increased IGF2 levels correlate with
increased invasiveness [30,31]. We therefore sought to determine
whether IGF2-induced signaling is required for the migration and in-
vasion activities of HCC cells.
Treatment of MM189 HCC cells possessing high migration and
invasion potential, and high expression of IGF2 [31], with a neutral-
izing antibody (Figure 1A) reduced cell migration and invasion in
transwell assays, suggesting that IGF2 is a key component in these
phenotypes. To confirm that this effect was due to the specific neu-
tralization of IGF2, we infected MM189 cells with a lentiviral vector
encoding IGF2-targeting shRNA. We confirmed knockdown of IGF2
by immunoblot analysis of cell lysates (Figure 1B) and conditioned
serum-free medium (Figure 1C ). The specificity of the knockdown
was confirmed by the maintenance of IGF1 levels in conditioned
serum-free medium collected from knockdown cells relative to controls
(Figure 1C ). ShRNA-mediated knockdown of IGF2 decreased cell mi-
gration and invasion (Figure 1D), further supporting a role for IGF2
in these phenotypes. Importantly, incubation of IGF2 knockdown cells
with conditioned serum-free medium from control cells more effec-
tively restored their invasion activity than incubation with conditioned
medium from knockdown cells (Figure 1E ). We next determined
whether ectopic administration of IGF2 was sufficient to induce cell
migration or invasion. Incubation of MM189 cells in the presence of
recombinant IGF2 (but the absence of serum) failed to stimulate cell mi-
gration or invasion (Figure 1F ). Together, these findings demonstrate
that IGF2 is a critical stimulator of HCC cell migration and invasion
but is not able to induce these phenotypes on its own.
Previous studies have suggested that IGF2 signals through the IGF1R
but may also signal through the IR or IGF1R/IR heterodimers [6].
To ascertain whether IGF1R-mediated signaling is required for HCC
cell migration and invasion, we introduced lentiviral vectors encoding
shRNA targeting IGF1R into MM189 cells and confirmed efficient
knockdown of IGF1R expression by two independent targeting shRNA
by immunoblot analysis for the IGF1Rβ subunit (Figure 2A). Interest-
ingly, the expression of IGF1R-targeting shRNA inhibited tumor cell
migration and invasion (Figure 2B). To confirm that this phenomenon
is not restricted to a single cell line, we performed similar experiments in
the BL322 HCC cell line [30]. We observed that IGF1R knock-
down impaired the migration and invasion activities of these cells (Fig-
ure 2, C and D). Thus, these data demonstrate that IGF1R-mediated
signaling is required for the migration and invasion activities of HCC
cell lines.
To determine whether IR-mediated signaling is involved in the mi-
gration and invasion phenotypes, we infected MM189 cells with lenti-
viral vectors encoding IR-targeting shRNA and documented reduced IR
expression by immunoblot (Figure 2E). In transwell assays, reduced IR
levels did not impair tumor cell migration and invasion (Figure 2F ), sug-
gesting that IR-mediated signaling is not required for these phenotypes.
Migration and invasion assays were also performed in the presence
of increasing concentrations of the compound AG1024. AG1024 is a
competitive inhibitor of IGF1R kinase activity and, at higher concen-
trations, of IR activity as well [32]. Consistent with the data obtained
after shRNA-mediated knockdown of either IGF1R or IR, low con-
centrations of AG1024, below the half-maximal inhibitory concentra-
tion for IR, effectively inhibited the invasion activity of this HCC cell
line (Figure W1). Collectively, the previously mentioned data demon-
strated that IGF1R but not IR is required for IGF2-mediated HCC cell
migration and invasion.
IGF1R-Mediated Signaling Is Required for the
Metastatic Phenotype
The previously mentioned data demonstrate that IGF2-stimulated
IGF1R-mediated signaling is required for HCC cell migration and in-
vasion. To ascertain whether this correlated with an in vivo phenotype,
we determined the ability of MM189 cells with IGF1R knockdown, or
empty vector controls, to colonize the lungs after introduction into the
circulation through the tail vein. We observed that IGF1R knockdown
led to a dramatic alteration of the phenotype in this assay. Whereas con-
trol cells readily colonized the lungs and formed large masses within
this tissue, there was an 80% reduction in the number of lesions and
a 90% reduction in the size of lesions in the lung after injection of
cells expressing either of two shRNAhairpins targeting IGF1R (Figure 3,
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A–C). Thus, IGF1R-stimulated signaling is required for lung coloniza-
tion in vivo.
In contrast, and consistent with the findings in the transwell assays,
MM189 cells expressing IR-targeting shRNA colonized the lungs as
effectively as control cells did (Figure 3D). IR knockdown cells did
not display a reduction either in the number of lesions that formed
or in the lung area occupied by these lesions (Figure 3, E and F ). Inter-
estingly, shRNA-mediated knockdown of IGF2 did not result in a de-
crease in the number of lesions within the lungs and resulted in a
modest but statistically insignificant decrease in tumor area within the
lung after tail vein injection (Figure 4, A–C). Together, these data dem-
onstrate that IGF1R-stimulated signaling, but not IR- or IGF1R/IR–
stimulated signaling, is important for metastasis-associated phenotypes.
IGF1R-Mediated Signaling Is Not Required for Subcutaneous
Tumor Formation
These findings indicate an important role for IGF1R-mediated
signaling in HCC cell migration, invasion, and lung colonization.
We therefore asked whether IGF1R signaling plays important roles
in other phenotypes of HCC cells. We determined whether IGF1R
knockdown affected the ability of MM189 HCC cells to form tu-
mors after SC injection into the flanks of nude mice. Interestingly,
we did not observe any differences between IGF1R knockdown cells
and controls. IGF1R knockdown cells induced tumors with an aver-
age weight of 321 ± 101 mg compared with 325 ± 136 mg for con-
trols (Figure 5A). Likewise, RNAi-mediated inhibition of IGF2 did
not significantly impair SC tumor formation (Figure 5B), suggesting
Figure 1. IGF2 is required for HCC cell migration and invasion. (A) Migration (gray bars) and invasion (white bars) activities of MM189
HCC cells after inhibition of IGF2 using neutralizing antibodies. Error shown is SEM. The panel on the right displays the invasion index
(see Materials and Methods). Data are from a representative experiment. (B) Immunoblot of whole-cell lysates confirming knockdown of
IGF2 in MM189 HCC cells by a targeting shRNA. β-Actin serves as a loading control. (C) Immunoblot of conditioned serum-free medium
collected from IGF2 knockdown cells and controls to determine levels of secreted IGF2 and IGF1. (D) Migration (gray bars) and invasion
(white bars) activities of MM189 HCC cells after inhibition of IGF2 by shRNA. Error shown is SEM. The panel on the right displays the
invasion index. Data are from a representative experiment. (E) Migration and invasion activities of MM189 cells with IGF2 knockdown or
controls in the presence of serum-free medium (first two samples) or in the presence of serum-free conditioned medium collected from
either control MM189 cells or MM189 cells expressing IGF2 shRNA (last two samples). Error shown is SEM. The panel on the right
displays the invasion index. Data are from a representative experiment. (F) Migration (gray bars) and invasion (white bars) activities of
MM189 HCC cells stimulated with recombinant IGF2. Error shown is SEM. The panel on the right displays the invasion index. IGF2
concentrations are shown on the x-axis. Data are from a representative experiment.
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that IGF2-stimulated IGF1R signaling is not required for tumor for-
mation. Finally, RNAi-mediated inhibition of IR did not inhibit SC
tumor formation, suggesting that IR-mediated signaling is not required
for this phenotype either (Figure 5C).
Thus, combined with our previously mentioned findings, these
results indicate that IGF1R-mediated signaling is dispensable for
tumor development but is required for HCC cell migration, invasion,
and metastasis.
IGF1R-Stimulated HCC Cell Invasion Involves IRS2
Ligand binding to the IGF1R leads to autophosphorylation of the
receptor and binding of adapter IRS proteins [33]. mRNA for IRS 1
to 4 are detectable in the murine liver, and we have demonstrated
through reverse transcription–polymerase chain reaction (RT-PCR)
that all four are expressed in HCC tissues and cell lines generated in
our mouse model (data not shown).
Previous studies have demonstrated opposite roles for IRS1 and IRS2
in the metastasis of mammary tumor cells in a mouse model of the dis-
ease [34,35]. We therefore sought to determine whether the signals
downstream of IGF1R in HCC cell migration and invasion are medi-
ated by IRS1, IRS2, or both. To explore this question, we generated
MM189 cells with shRNA-induced knockdown of IRS1 or IRS2 and
measured the migration and invasion activities of these cells. First, we
confirmed by immunoblot that knockdown was specific for each of
the IRS proteins (Figure 6A). We next measured the migration and in-
vasion activities of the knockdown cells relative to controls. We found
that IRS2 knockdown, but not IRS1 knockdown, reduced invasion ac-
tivity (Figure 6, B and C ). Thus, our results indicate that the effect
Figure 2. IGF1R-mediated, but not IR-mediated, signaling is required for HCC cell migration and invasion. (A) Immunoblot confirming
knockdown of IGF1R in MM189 HCC cells by independent targeting shRNA. β-Actin serves as a loading control. (B) Migration (gray bars)
and invasion (white bars) activities of vector controls and MM189 cells with IGF1R knockdown. Error shown is SEM. The panel on the
right displays the invasion index. Data are from a representative experiment. (C) Immunoblot confirming knockdown of IGF1R in BL322
HCC cells by independent targeting shRNA. β-Actin serves as a loading control. (D) Migration (gray bars) and invasion (white bars) ac-
tivities of vector controls and BL322 cells with IGF1R knockdown. Error shown is SEM. The panel on the right displays the invasion
index. Data are from a representative experiment. (E) Immunoblot confirming knockdown of IR by targeting shRNA. (F) Migration (gray
bars) and invasion (white bars) activities of vector controls and MM189 cells with IR knockdown. The panel on the right displays the
invasion index. Data are from a representative experiment.
Neoplasia Vol. 11, No. 9, 2009 IGF-induced Signaling and HCC Metastasis Chen et al. 839
of IGF1R on the invasion activity of HCC cells is primarily mediated
by IRS2.
MMP2 Is a Mediator of IGF1R-Mediated HCC Cell Invasion
To identify potential mediators of the IGF1R-inducedmigration and
invasion phenotypes in MM189 HCC cells, we assayed the mRNA
levels of several candidate genes in IGF1R knockdown cells and con-
trols by quantitative RT-PCR (qRT-PCR). We determined the levels
of the transcription factors Snail and Twist and the matrix metallo-
proteinases MMP2, MMP3, and MMP9 because all of these factors
have been previously shown to be involved in tumor cell migration
and/or invasion [36,37]. We observed that the levels of Snail are not
altered in cells lacking IGF1R, whereas Twist1 mRNA levels are slightly
elevated in these cells (Figure 7A). However, MMP2 mRNA levels are
greatly reduced in cells with IGF1R knockdown relative to controls
(Figure 5A), whereas MMP9 levels are modestly reduced, consistent
with regulation of MMP2 by IGF signaling in other cancer cell lines
[38–40]. This change does not reflect a general reduction in MMP-
encoding mRNA because MMP3 mRNA levels are elevated in IGF1R
knockdown cells relative to controls (Figure 7A). Importantly, shRNA-
mediated knockdown of IGF2, but not the IR, similarly reduced
MMP2 mRNA levels (Figure 7B). Consistent with the RT-PCR data,
the activity of MMP2 was reduced in conditioned serum-free medium
collected from IGF1R knockdown cells relative to controls (Figure 7C).
These data indicate that IGF2-induced IGF1R signaling stimulates the
expression of MMP2.
We next determined whether inhibition of MMP2 reduced the mi-
gration and invasion activities of MM189 cells. We found that treat-
ment of MM189 cells with 10 μM of an MMP2 inhibitor reduced
cell invasion but not migration (Figure 7D). These data suggest that
MMP2 acts downstream of IGF1R to regulate HCC cell invasion.
To determine how IGF signaling may regulate MMP2 levels, we
treated MM189 cells with the IGF1R inhibitor AG1024, or with spe-
cific inhibitors against PI3-kinase or MAP kinase kinase, and measured
MMP2 mRNA levels relative to vehicle-treated controls. We observed
that blockade of PI3 kinase signaling modestly reduced MMP2 mRNA
levels, whereas MAP kinase signaling blockade did not, suggesting that
PI3 kinase signaling mediates, at least in part, IGF2-induced MMP2
expression (Figure 7E).
Discussion
IGF-induced signaling has been implicated in the pathogenesis of
several human malignancies [2]. In particular, induction of IGF sig-
naling, by a variety of mechanisms, has been implicated in HCC.
Indeed, the induction of IGF2 gene expression is a common event in
HCC, and serum levels of IGF2 mRNA correlate well with the pres-
ence of extrahepatic metastases in this disease [17,29]. In agreement
with these findings, we have previously shown that elevated IGF2
mRNA levels identify tumors with enhanced metastatic potential in a
novel HCC mouse model [21].
We therefore sought to determine the role of IGF2-induced signaling
in the metastatic capability of HCC cells. Although exogenous IGF2
was insufficient to stimulate HCC cell migration and invasion, we ob-
served that knockdown of IGF2, as well as blockade with anti-IGF2
antibodies, impaired the ability of HCC cells to migrate and invade
in transwell assays, indicating that IGF2 is required for these phenotypes
and that IGF2 may act in an autocrine manner to induce these effects.
Using an shRNA-mediated inhibition strategy, we found that IGF1R-
mediated signaling is required for cell migration and invasion in vitro,
Figure 3. IGF1R signaling is required for lung colonization. (A) Representative lung fields of nude mice after the delivery of MM189 cells
with IGF1R knockdown or vector controls through tail vein injection. The boxed area in the upper panel is shown at a higher magnifi-
cation in the lower panel. Quantification of the number of lung lesions (B) and total tumor area (C) in the lungs of mice injected with
MM189 cells with IGF1R knockdown or vector controls. Error shown is SEM. *P < .01 by Student’s t test. **P < .05 by Student’s t test.
(D) Representative lung fields of nude mice after the delivery of MM189 cells with IR knockdown or vector controls through tail vein
injection. The boxed area in the upper panel is shown at a higher magnification in the lower panel. Quantification of the number of lung
lesions (E) and total tumor area (F) in the lungs of mice injected with MM189 cells with IR knockdown or vector controls. Error shown is
SEM. P, not significant.
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indicating that IGF2 signals through this receptor to stimulate these
phenotypes. These findings are consistent with a recent report showing
that IGF1R inhibition impaired the migration of HCC cells in a wound
healing assay [41]. Importantly, we also observed that IGF1R-mediated
signaling is required for lung colonization in vivo, providing experi-
mental support for the connection between IGF2 expression and extra-
hepatic metastasis in HCC patients. Our results are consistent with
previous findings indicating roles for IGF1R-mediated signaling in the
metastasis of other tumor types [4].
Interestingly, whereas IGF1R knockdown impaired tumor lung
colonization, knockdown of IGF2 had only a modest effect, perhaps
suggesting that in vivo circulating IGFs produced by the recipient
animals may stimulate the IGF1R signaling cascade in the injected
HCC cells, circumventing the need for the cells to produce IGF2.
Figure 4. Inhibition of IGF2 does not block lung colonization. (A) Representative lung fields of nude mice after the delivery of MM189
cells with IGF2 knockdown or vector controls through tail vein injection. The boxed area in the upper panel is shown at higher magni-
fication in the lower panel. Quantification of the number of lung lesions (B) and total tumor area (C) in the lungs of mice injected with
MM189 cells with IGF2 knockdown or vector controls. Error shown is SEM. P, not significant.
Figure 5. IGF2-induced signaling is not required for SC tumor formation. Effect of RNAi-mediated depletion of IGF1R (A), IGF2 (B), or IR
(C) on SC tumor growth of MM189 HCC cells. pLKO- or pLKO-GFP–infected cells are used as vector controls.
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Another possibility is that IGF2 is important at an earlier step in
metastasis, such as the migration and invasion of tumor cells away
from the primary site and into the circulation, a step that is circum-
vented in this particular assay. This hypothesis is consistent with our
in vitro migration and invasion data.
In contrast to the importance of IGF1R-stimulated signaling in
lung colonization by HCC cells, we observed that IGF1R-mediated
signaling was not required for tumor growth after the SC injection of
tumor cells. The different results obtained in the SC tumor assay and
the lung colonization assay also suggest the possibility that IGF1R sig-
naling is specifically required for tumor progression but not for tumor
development per se. Further experiments are required to test this hy-
pothesis and to provide mechanistic insights into how this might occur.
However, these observations are consistent with findings reported in
mammary tumorigenesis [42,43].
Our results contrast with those of Nussbaum et al. [41] who found
that inhibition of IGF1R signaling using small molecules impaired
tumor growth. A potential explanation for this discrepancy is that in
addition to impairing IGF1R signaling in tumor cells, treatment of
mice with small-molecule antagonists also impairs IGF1R signaling
in stromal cells such as fibroblasts and vascular endothelial cells that
are critical for tumor growth. Our use of shRNA specifically targets
IGF1R signaling within the tumor cells and therefore allows more pre-
cise evaluation of the requirement for IGF1R-stimulated signaling
cascades in tumor development.
Previous studies have suggested that in addition to IGF1R, IGFs
may signal through IGF1R/IR heterodimers and IR-A homodimers
[6]. Of significance, our results demonstrate that IGF1R-mediated,
but not IR-mediated signaling, is required for many of the pheno-
types assayed. These results are consistent with recent findings on
the effects of IGF1R, but not IR, on the viability, proliferation, and
migration of human HCC cells [41]. These results suggest, that
in HCC cells, IGF ligands signal through IGF1R holoreceptors, not
IGF1R/IR heterodimers, and that insulin signaling is not important
Figure 6. IGF1R-mediated HCC cell invasion involves IRS2. (A) Immunoblot confirming specific knockdown of either IRS1 or IRS2 using
targeting shRNA. β-Actin serves as a loading control. Invasion activity of MM189 HCC cells with knockdown of either IRS2 (B) or IRS1
(C). Migration (gray bars) and invasion (white bars) activities of vector controls and cells with indicated knockdown. Error shown is SEM.
The panel on the right displays the invasion index. Data are from representative experiments.
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for transformation phenotypes in HCC, despite the fact that the
liver is a critical site of insulin action. Further, these results suggest
that although the IGF1R and IR share common downstream IRS
adapter proteins, the signals stimulated downstream of these receptors
are different.
Consistent with this idea, knockdown of IRS2, but not IRS1, par-
tially recapitulated themigration and invasion defect observed in IGF1R
depleted cells. The involvement of IRS2 in the invasion phenotype
is consistent with its role in tumor metastasis in mouse models of
human cancer [35]. However, IRS2 knockdown does not induce as
severe a phenotype as IGF1R depletion (nor does concomitant knock-
down of IRS1 and IRS2). This suggests that signals propagated down-
stream of IGF1R independently of the IRS proteins play critical roles in
these phenotypes.
Indeed, the identities of the downstream signaling pathways important
for the metastasis-related phenotypes induced by IGF1R-stimulated
signaling remain unknown. Direct pharmacologic inhibition of these
pathways in our HCC cell lines is an unfeasible approach because these
inhibitors block the transforming activity of PyMT, the initiating onco-
protein in these cell lines. We have previously demonstrated that treat-
ment of these HCC cell lines with the mTOR antagonist rapamycin
impairs invasion [31], and our unpublished results show that blockade
of MAP kinase or PI3 kinase signaling potently impairs tumor cell mi-
gration and invasion (Y.-W. Chen and B. Lewis, unpublished data).
Thus, rescue experiments in which IGF1R mutants defective in stimu-
lating specific downstream signaling pathways are used to reverse the
invasion defect caused by IGF1R knockdown will be needed to address
this issue.
Figure 7. MMP2 mediates IGF1R-induced cell invasion. (A) qRT-PCR data demonstrating the relative mRNA levels for the indicated
genes in IGF1R knockdown cells and vector controls. (B) qRT-PCR measurement of MMP2 mRNA levels in cells with either IGF2
or IR knockdown. (C) Gelatinase zymogaphy demonstrating the activity of secreted MMP2 and MMP9 in IGF1R knockdown cells and
vector controls. (D) Migration (gray bars) and invasion activities (white bars) of MM189 cells treated with an MMP2 inhibitor. Error
shown is SEM. The panel on the right displays the invasion index. Data are from a representative experiment. (E) Measurement of
MMP2 mRNA levels in MM189 HCC cells treated with inhibitors targeting the IGF1R, MAP kinase signaling pathway, or the PI3 kinase
signaling pathway.
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What also remain unclear are the identities of the terminal ef-
fectors that mediate IGF-induced cell migration and invasion. Using
a candidate gene approach, we showed that MMP2 is involved in
IGF1R-mediated invasion, yet MMP2 inhibition does not produce
as severe an impact on cell invasion as IGF1R inhibition, indicating
that other critical players remain to be identified. It is likely that a more
global approach may identify important players in this process. Indeed,
Nussbaum et al. [41] recently reported that IGF signaling induces the
expression of several genes involved in motility. An intriguing pos-
sibility, yet to be tested experimentally, is that the metastatic pheno-
type induced by IGF signaling is dependent on the inhibition of
FoxO transcription factors, recently shown to act as tumor suppressors
in vivo [44].
In summary, we have demonstrated a critical role for IGF-stimulated
signaling in metastasis-associated phenotypes in HCC cells. These data
provide further support for the pathologic significance of IGF2 gene
reactivation in HCCs and suggest that interfering with this signaling
pathway may be a critical strategy in treating HCC patients with dis-
seminated disease.
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Figure W1. (A) Migration (gray bars) and invasion (white bars) activities of MM189 HCC cells after treatment with the small-molecule
AG1024. Error shown is SEM. (B) Data displayed as the invasion index (see Materials and Methods). AG1024 concentrations are shown
on the x-axis. Data are from a representative experiment.
